{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T02:09:32Z","timestamp":1792289372977,"version":"4.4.0"},"reference-count":119,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2011,8,1]],"date-time":"2011-08-01T00:00:00Z","timestamp":1312156800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,8,22]],"date-time":"2013-08-22T00:00:00Z","timestamp":1377129600000},"content-version":"vor","delay-in-days":752,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2011,8]]},"DOI":"10.1016\/j.ijid.2011.03.021","type":"journal-article","created":{"date-parts":[[2011,5,26]],"date-time":"2011-05-26T19:13:02Z","timestamp":1306437182000},"page":"e525-e532","source":"Crossref","is-referenced-by-count":265,"title":["Recent advances in leishmaniasis treatment"],"prefix":"10.1016","volume":"15","author":[{"given":"Tatiana S.","family":"Tiuman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana O.","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T\u00e2nia","family":"Ueda-Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedito P. Dias","family":"Filho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celso V.","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijid.2011.03.021_bib0005","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.cimid.2004.03.004","article-title":"Leishmaniasis: current situation and new perspectives","volume":"27","author":"Desjeux","year":"2004","journal-title":"Comp Immunol Microbiol Infect Dis"},{"key":"10.1016\/j.ijid.2011.03.021_bib0010","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1016\/S0140-6736(05)67629-5","article-title":"Advances in leishmaniasis","volume":"366","author":"Murray","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.ijid.2011.03.021_bib0015","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S1473-3099(07)70209-8","article-title":"Cutaneous leishmaniasis","volume":"7","author":"Reithinger","year":"2007","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijid.2011.03.021_bib0020","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/S0035-9203(00)90055-5","article-title":"Visceral leishmaniasis control: a public health perspective","volume":"94","author":"Boelaert","year":"2000","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.ijid.2011.03.021_bib0025","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.pt.2006.06.012","article-title":"Phlebotomine sand flies and Leishmania parasites: friends or foes?","volume":"22","author":"Kamhawi","year":"2006","journal-title":"Trends Parasitol"},{"key":"10.1016\/j.ijid.2011.03.021_bib0030","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/S0020-7519(01)00259-4","article-title":"Life in vacuoles\u2014nutrient acquisition by Leishmania amastigotes","volume":"31","author":"Burchmore","year":"2001","journal-title":"Int J Parasitol"},{"key":"10.1016\/j.ijid.2011.03.021_bib0035","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1046\/j.1365-2230.2000.00664.x","article-title":"Cutaneous leishmaniasis","volume":"25","author":"Hepburn","year":"2000","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.ijid.2011.03.021_bib0040","unstructured":"World Health Organization. Visceral leishmaniasis therapy: statement on the outcome of a meeting. Geneva: WHO; 2009. Available at: http:\/\/www.who.int\/leishmaniasis\/resources\/Leish_VL_Therapy_statement.pdf (accessed August 16, 2010)."},{"key":"10.1016\/j.ijid.2011.03.021_bib0045","doi-asserted-by":"crossref","first-page":"617521","DOI":"10.1155\/2010\/617521","article-title":"Drug resistance in visceral leishmaniasis","volume":"2010","author":"Maltezou","year":"2010","journal-title":"J Biomed Biotechnol"},{"key":"10.1016\/j.ijid.2011.03.021_bib0050","unstructured":"World Health Organization. Leishmaniasis: magnitude of the problem. Geneva: WHO; 2009. Available at: http:\/\/www.who.int\/leishmaniasis\/burden\/magnitude\/burden_magnitude\/en\/index.html (accessed November 30, 2010)."},{"key":"10.1016\/j.ijid.2011.03.021_bib0055","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1590\/S0074-02762007000500001","article-title":"The leishmaniases\u2014survival and expansion in a changing world","volume":"102","author":"Shaw","year":"2007","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"10.1016\/j.ijid.2011.03.021_bib0060","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.actatropica.2003.09.009","article-title":"Visceral leishmaniasis in immunocompromised patients with and without AIDS: a comparison of clinical features and prognosis","volume":"90","author":"Fern\u00e1ndez-Guerrero","year":"2004","journal-title":"Acta Trop"},{"key":"10.1016\/j.ijid.2011.03.021_bib0065","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.ijid.2009.01.022","article-title":"Atypical disseminated leishmaniasis similar to post-kala-azar dermal leishmaniasis in a Brazilian AIDS patient infected with Leishmania (Leishmania) infantum chagasi: a case report","volume":"13","author":"Carna\u00faba","year":"2009","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.ijid.2011.03.021_bib0070","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.pt.2005.08.026","article-title":"Chemotherapy of trypanosomiases and leishmaniasis","volume":"21","author":"Croft","year":"2005","journal-title":"Trends Parasitol"},{"key":"10.1016\/j.ijid.2011.03.021_bib0075","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.ijantimicag.2007.01.004","article-title":"Leishmania spp: pro\ufb01ciency of drug-resistant parasites","volume":"29","author":"Natera","year":"2007","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijid.2011.03.021_bib0080","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1128\/CMR.19.1.111-126.2006","article-title":"Drug resistance in leishmaniasis","volume":"19","author":"Croft","year":"2006","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.ijid.2011.03.021_bib0085","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/S0140-6736(98)10178-2","article-title":"Leishmaniasis","volume":"2","author":"Herwaldt","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.ijid.2011.03.021_bib0090","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.provac.2009.07.018","article-title":"Development of immunization strategies against leishmaniosis based on the Leishmania histones pathoantigens","volume":"1","author":"Carri\u00f3n","year":"2009","journal-title":"Procedia Vaccinol"},{"key":"10.1016\/j.ijid.2011.03.021_bib0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.actatropica.2007.08.003","article-title":"Mucosal leishmaniasis. Current scenario and prospects for treatment","volume":"105","author":"Amato","year":"2008","journal-title":"Acta Trop"},{"key":"10.1016\/j.ijid.2011.03.021_bib0100","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1086\/518041","article-title":"Influence of Leishmania (Viannia) species on the response to antimonial treatment in patients with American tegumentary leishmaniasis","volume":"195","author":"Arevalo","year":"2007","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijid.2011.03.021_bib0105","unstructured":"Centers for Disease Control and Prevention (CDC). Parasites\u2014leishmaniasis. Resources for health professionals. Atlanta, GA: CDC; 2010. Available at: http:\/\/www.cdc.gov\/parasites\/leishmaniasis\/health_professionals\/index.html (accessed December 2, 2010)."},{"key":"10.1016\/j.ijid.2011.03.021_bib0110","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.drup.2004.07.002","article-title":"Leishmaniasis: drugs in the clinic, resistance and new developments","volume":"7","author":"Ouellette","year":"2004","journal-title":"Drug Resist Updat"},{"key":"10.1016\/j.ijid.2011.03.021_bib0115","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.pt.2003.09.008","article-title":"Leishmaniasis\u2014current chemotherapy and recent advances in the search for novel drugs","volume":"19","author":"Croft","year":"2003","journal-title":"Trends Parasitol"},{"key":"10.1016\/j.ijid.2011.03.021_bib0120","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0924-8579(99)00133-8","article-title":"A comparison of the activities of three amphotericin B lipid formulations against experimental visceral and cutaneous leishmaniasis","volume":"13","author":"Yardley","year":"2000","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijid.2011.03.021_bib0125","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.ijantimicag.2007.05.013","article-title":"In vitro effect of new formulations of amphotericin B on amastigote and promastigote forms of Leishmania infantum","volume":"30","author":"Ord\u00f3\u00f1ez-Guti\u00e9rrez","year":"2007","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijid.2011.03.021_bib0130","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.trstmh.2006.02.010","article-title":"Development of miltefosine as an oral treatment for leishmaniasis","volume":"100","author":"Sindermann","year":"2006","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.ijid.2011.03.021_bib0135","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.trstmh.2006.03.009","article-title":"Miltefosine\u2014discovery of the antileishmanial activity of phospholipid derivatives","volume":"100","author":"Croft","year":"2006","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.ijid.2011.03.021_bib0140","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.trstmh.2006.02.009","article-title":"Miltefosine: issues to be addressed in the future","volume":"100","author":"Berman","year":"2006","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.ijid.2011.03.021_bib0145","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.drup.2006.04.001","article-title":"Mechanisms of experimental resistance of Leishmania to miltefosine: implications for clinical use","volume":"9","author":"P\u00e9rez-Victoria","year":"2006","journal-title":"Drug Resist Updat"},{"key":"10.1016\/j.ijid.2011.03.021_bib0150","first-page":"394","article-title":"Availability of miltefosine for the treatment of kala-azar in India","volume":"83","author":"Sundar","year":"2005","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.ijid.2011.03.021_bib0155","first-page":"733","article-title":"Miltefosine in the treatment of leishmaniasis: clinical evidence for informed clinical risk management","volume":"3","author":"Sundar","year":"2007","journal-title":"Ther Clin Risk Manag"},{"key":"10.1016\/j.ijid.2011.03.021_bib0160","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1093\/jac\/dkh380","article-title":"Effect of the lysophospholipid analogues edelfosine, ilmofosine and miltefosine against Leishmania amazonensis","volume":"54","author":"Santa-Rita","year":"2004","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijid.2011.03.021_bib0165","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1007\/s00436-006-0408-4","article-title":"In vitro activity of perifosine: a novel alkylphospholipid against the promastigote stage of Leishmania species","volume":"100","author":"Cabrera-Serra","year":"2007","journal-title":"Parasitol Res"},{"key":"10.1016\/j.ijid.2011.03.021_bib0170","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.actatropica.2008.08.005","article-title":"In vivo activity of perifosine against Leishmania amazonensis","volume":"108","author":"Cabrera-Serra","year":"2008","journal-title":"Acta Trop"},{"key":"10.1016\/j.ijid.2011.03.021_bib0175","doi-asserted-by":"crossref","first-page":"871","DOI":"10.4269\/ajtmh.2005.73.871","article-title":"A phase II dose-increasing study of sitamaquine for the treatment of visceral leishmaniasis in Kenya","volume":"73","author":"Wasunna","year":"2005","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.ijid.2011.03.021_bib0180","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0035-9203(02)90063-5","article-title":"Drug sensitivity of Leishmania species: some unresolved problems","volume":"96","author":"Croft","year":"2002","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.ijid.2011.03.021_bib0185","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1056\/NEJMoa066536","article-title":"Injectable paromomycin for visceral leishmaniasis in India","volume":"356","author":"Sundar","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijid.2011.03.021_bib0190","doi-asserted-by":"crossref","first-page":"162","DOI":"10.4269\/ajtmh.1995.53.162","article-title":"A randomized, placebo-controlled trial in Tunisia treating cutaneous leishmaniasis with paromomycin ointment","volume":"53","author":"Ben Salah","year":"1995","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.ijid.2011.03.021_bib0195","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.actatropica.2004.03.009","article-title":"Comparison of the effectiveness of two topical paromomycin treatments versus meglumine antimoniate for New World cutaneous leishmaniasis","volume":"91","author":"Armijos","year":"2004","journal-title":"Acta Trop"},{"key":"10.1016\/j.ijid.2011.03.021_bib0200","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.actatropica.2004.10.007","article-title":"Activity of a paromomycin hydrophilic formulation for topical treatment of infections by Leishmania (Leishmania) amazonensis and Leishmania (Viannia) braziliensis","volume":"93","author":"Gon\u00e7alves","year":"2005","journal-title":"Acta Trop"},{"key":"10.1016\/j.ijid.2011.03.021_bib0205","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/0169-4758(94)90398-0","article-title":"Medicinal plants in the fight against leishmaniasis","volume":"10","author":"Iwu","year":"1994","journal-title":"Parasitol Today"},{"key":"10.1016\/j.ijid.2011.03.021_bib0210","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.phymed.2003.10.006","article-title":"A review of natural products with antileishmanial activity","volume":"12","author":"Rocha","year":"2005","journal-title":"Phytomedicine"},{"key":"10.1016\/j.ijid.2011.03.021_bib0215","first-page":"4299","article-title":"New compounds of natural resources in 2008","volume":"8","author":"Wang","year":"2009","journal-title":"Afr J Biotechnol"},{"key":"10.1016\/j.ijid.2011.03.021_bib0220","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S0041-0101(00)00154-9","article-title":"Plants as source of drugs","volume":"39","author":"Rates","year":"2001","journal-title":"Toxicon"},{"key":"10.1016\/j.ijid.2011.03.021_bib0225","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0378-8741(97)00123-2","article-title":"Which extractant should be used for the screening and isolation of antimicrobial components from plants?","volume":"60","author":"Eloff","year":"1998","journal-title":"J Ethnopharmacol"},{"key":"10.1016\/j.ijid.2011.03.021_bib0230","doi-asserted-by":"crossref","DOI":"10.1002\/0471141755.ph0911s46","article-title":"Natural products as a foundation for drug discovery","volume":"46","author":"Beutler","year":"2009","journal-title":"Curr Protoc Pharmacol"},{"key":"10.1016\/j.ijid.2011.03.021_bib0235","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.parint.2006.09.001","article-title":"Advances and perspectives in Leishmania cell based drug-screening procedures","volume":"56","author":"Sereno","year":"2007","journal-title":"Parasitol Int"},{"key":"10.1016\/j.ijid.2011.03.021_bib0240","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1006\/expr.1996.0053","article-title":"Leishmania amazonensis: cultivation and characterization of axenic amastigote-like organisms","volume":"83","author":"Hodgkinson","year":"1996","journal-title":"Exp Parasitol"},{"key":"10.1016\/j.ijid.2011.03.021_bib0245","first-page":"399","article-title":"Current scenario of drug development for leishmaniasis","volume":"123","author":"Croft","year":"2006","journal-title":"Indian J Med Res"},{"key":"10.1016\/j.ijid.2011.03.021_bib0250","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1128\/AAC.41.4.818","article-title":"An axenic amastigote system for drug screening","volume":"41","author":"Callahan","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijid.2011.03.021_bib0255","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S1383-5769(99)00020-3","article-title":"A simple colorimetric method to screen drug cytotoxicity against Leishmania using the dye Alamar Blue","volume":"48","author":"Mikus","year":"2000","journal-title":"Parasitol Int"},{"key":"10.1016\/j.ijid.2011.03.021_bib0260","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.mimet.2005.10.011","article-title":"Development of a semi-automated colorimetric assay for screening anti-leishmanial agents","volume":"66","author":"Ganguly","year":"2006","journal-title":"J Microbiol Methods"},{"key":"10.1016\/j.ijid.2011.03.021_bib0265","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1007\/s00436-002-0706-4","article-title":"A microplate assay for Leishmania amazonensis promastigotes expressing multimeric green fluorescent protein","volume":"89","author":"Chan","year":"2003","journal-title":"Parasitol Res"},{"key":"10.1016\/j.ijid.2011.03.021_bib0270","first-page":"5","article-title":"Leishmania amastigotes as targets for drug screening","volume":"23","author":"Monte-Alegre","year":"2006","journal-title":"Kinetoplastid Biol Dis"},{"key":"10.1016\/j.ijid.2011.03.021_bib0275","first-page":"475","article-title":"High-throughput screening of amastigotes of Leishmania donovani clinical isolates against drugs using a colorimetric beta-lactamase assay","volume":"47","author":"Mandal","year":"2009","journal-title":"Indian J Exp Biol"},{"key":"10.1016\/j.ijid.2011.03.021_bib0280","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.jep.2009.02.008","article-title":"Anti-parasitic activity and cytotoxicity of selected medicinal plants from Kenya","volume":"25","author":"Kigondu","year":"2009","journal-title":"J Ethnopharmacol"},{"key":"10.1016\/j.ijid.2011.03.021_bib0285","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.phymed.2003.10.007","article-title":"Antiprotozoal activity of Brazilian plant extracts from isoquinoline alkaloid-producing families","volume":"12","author":"Tempone","year":"2005","journal-title":"Phytomedicine"},{"key":"10.1016\/j.ijid.2011.03.021_bib0290","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.jep.2007.01.015","article-title":"Antiprotozoal and cytotoxic activities in vitro of Colombian Annonaceae","volume":"22","author":"Osorio","year":"2007","journal-title":"J Ethnopharmacol"},{"key":"10.1016\/j.ijid.2011.03.021_bib0295","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.jep.2005.06.011","article-title":"In vitro cytotoxic, antileishmanial and antifungal activities of ethnopharmacologically selected Gabonese plants","volume":"14","author":"Lamidi","year":"2005","journal-title":"J Ethnopharmacol"},{"key":"10.1016\/j.ijid.2011.03.021_bib0300","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.jep.2007.03.025","article-title":"Spirolactone iridoids might be responsible for the antileishmanial activity of a Peruvian traditional remedy made with Himatanthus sucuuba (Apocynaceae)","volume":"13","author":"Castillo","year":"2007","journal-title":"J Ethnopharmacol"},{"key":"10.1016\/j.ijid.2011.03.021_bib0305","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.jep.2004.10.006","article-title":"Screening of New Caledonian and Vanuatu medicinal plants for antiprotozoal activity","volume":"15","author":"Billo","year":"2005","journal-title":"J Ethnopharmacol"},{"key":"10.1016\/j.ijid.2011.03.021_bib0310","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1179\/136485910X12786389891281","article-title":"Antileishmanial activity of an essential oil from the leaves and flowers of Achillea millefolium","volume":"104","author":"Santos","year":"2010","journal-title":"Ann Trop Med Parasitol"},{"key":"10.1016\/j.ijid.2011.03.021_bib0315","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.phymed.2008.12.008","article-title":"Trypanocidal, leishmanicidal and cytotoxic effects of anthecotulide-type linear sesquiterpene lactones from Anthemis auriculata","volume":"16","author":"Karioti","year":"2009","journal-title":"Phytomedicine"},{"key":"10.1016\/j.ijid.2011.03.021_bib0320","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.fitote.2009.06.007","article-title":"In vitro antileishmanial, antiplasmodial and cytotoxic activities of phenolics and triterpenoids from Baccharis dracunculifolia D. C. (Asteraceae)","volume":"80","author":"Silva Filho","year":"2009","journal-title":"Fitoterapia"},{"key":"10.1016\/j.ijid.2011.03.021_bib0325","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.jep.2009.03.041","article-title":"Medicinal plants from the Yanesha (Peru): evaluation of the leishmanicidal and antimalarial activity of selected extracts","volume":"123","author":"Valadeau","year":"2009","journal-title":"J Ethnopharmacol"},{"key":"10.1016\/j.ijid.2011.03.021_bib0330","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.jep.2010.01.007","article-title":"Assessment of anti-protozoal activity of plants traditionally used in Ecuador in the treatment of leishmaniasis","volume":"2","author":"Gachet","year":"2010","journal-title":"J Ethnopharmacol"},{"key":"10.1016\/j.ijid.2011.03.021_bib0335","first-page":"245","article-title":"Studies on the effectiveness of Tanacetum parthenium against Leishmania amazonensis","volume":"44","author":"Tiuman","year":"2005","journal-title":"Acta Protozool"},{"key":"10.1016\/j.ijid.2011.03.021_bib0340","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1128\/AAC.49.11.176-182.2005","article-title":"Antileishmanial activity of parthenolide, a sesquiterpene lactone isolated from Tanacetum parthenium","volume":"49","author":"Tiuman","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijid.2011.03.021_bib0345","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.parint.2010.08.005","article-title":"Antileishmanial activity of a guaianolide from Tanacetum parthenium (L.) Schultz Bip","volume":"59","author":"Silva","year":"2010","journal-title":"Parasitol Int"},{"key":"10.1016\/j.ijid.2011.03.021_bib0350","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.jep.2006.12.006","article-title":"Antileishmanial and antifungal activity of plants used in traditional medicine in Brazil","volume":"4","author":"Braga","year":"2007","journal-title":"J Ethnopharmacol"},{"key":"10.1016\/j.ijid.2011.03.021_bib0355","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1007\/s00436-007-0542-7","article-title":"Antileishmanial activity of crude extract and coumarin from Calophyllum brasiliense leaves against Leishmania amazonensis","volume":"101","author":"Brenzan","year":"2007","journal-title":"Parasitol Res"},{"key":"10.1016\/j.ijid.2011.03.021_bib0360","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1016\/j.phytochem.2006.06.027","article-title":"The antileishmanial activity assessment of unusual flavonoids from Kalanchoe pinnata","volume":"67","author":"Muzitano","year":"2006","journal-title":"Phytochemistry"},{"key":"10.1016\/j.ijid.2011.03.021_bib0365","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.jep.2008.08.007","article-title":"Effect of Brazilian copaiba oils on Leishmania amazonensis","volume":"120","author":"Santos","year":"2008","journal-title":"J Ethnopharmacol"},{"key":"10.1016\/j.ijid.2011.03.021_bib0370","doi-asserted-by":"crossref","first-page":"5065","DOI":"10.1016\/j.bmcl.2005.07.090","article-title":"New clerodane diterpenoids from Laetia procera (Poepp.) Eichler (Flacourtiaceae), with antiplasmodial and antileishmanial activities","volume":"15","author":"Jullian","year":"2005","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.ijid.2011.03.021_bib0375","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.phymed.2004.10.008","article-title":"Comparative antiplasmodial, leishmanicidal and antitrypanosomal activities of several biflavonoids","volume":"13","author":"Weniger","year":"2006","journal-title":"Phytomedicine"},{"key":"10.1016\/j.ijid.2011.03.021_bib0380","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jep.2007.01.026","article-title":"Antiparasitic activity of some New Caledonian medicinal plants","volume":"30","author":"Desrivot","year":"2007","journal-title":"J Ethnopharmacol"},{"key":"10.1016\/j.ijid.2011.03.021_bib0385","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.parint.2005.10.006","article-title":"Antileishmanial activity of eugenol-rich essential oil from Ocimum gratissimum","volume":"55","author":"Ueda-Nakamura","year":"2006","journal-title":"Parasitol Int"},{"key":"10.1016\/j.ijid.2011.03.021_bib0390","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.phytochem.2005.10.028","article-title":"A triterpenoid saponin possessing antileishmanial activity from the leaves of Careya arborea","volume":"67","author":"Mandal","year":"2006","journal-title":"Phytochemistry"},{"key":"10.1016\/j.ijid.2011.03.021_bib0395","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.phytochem.2009.03.009","article-title":"Leishmanicidal effect of LLD-3 (1), a nor-triterpene isolated from Lophanthera lactescens","volume":"70","author":"Danelli","year":"2009","journal-title":"Phytochemistry"},{"key":"10.1016\/j.ijid.2011.03.021_bib0400","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.phymed.2005.10.002","article-title":"In vitro and in vivo leishmanicidal activity of Dysoxylum binectariferum and its fractions against Leishmania donovani","volume":"14","author":"Lakshmi","year":"2007","journal-title":"Phytomedicine"},{"key":"10.1016\/j.ijid.2011.03.021_bib0405","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1590\/S0074-02762010000200010","article-title":"Chemistry, cytotoxicity and antileishmanial activity of the essential oil from Piper auritum","volume":"105","author":"Monzote","year":"2010","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"10.1016\/j.ijid.2011.03.021_bib0410","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.jep.2007.08.007","article-title":"Evaluation of the leishmanicidal activity of plants used by Peruvian Chayahuita ethnic group","volume":"1","author":"Estevez","year":"2007","journal-title":"J Ethnopharmacol"},{"key":"10.1016\/j.ijid.2011.03.021_bib0415","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.parint.2009.12.009","article-title":"Evaluation of antileishmanial activity of eupomatenoid-5, a compound isolated from leaves of Piper regnellii var. pallescens","volume":"59","author":"Vendrametto","year":"2010","journal-title":"Parasitol Int"},{"key":"10.1016\/j.ijid.2011.03.021_bib0420","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1007\/s00436-009-1578-7","article-title":"In vitro activity of the essential oil of Cymbopogon citratus and its major component (citral) on Leishmania amazonensis","volume":"105","author":"Santin","year":"2009","journal-title":"Parasitol Res"},{"key":"10.1016\/j.ijid.2011.03.021_bib0425","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1021\/np100146y","article-title":"Coumarins from Galipea panamensis and their activity against Leishmania panamensis","volume":"28","author":"Arango","year":"2010","journal-title":"J Nat Prod"},{"key":"10.1016\/j.ijid.2011.03.021_bib0430","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.phymed.2007.07.032","article-title":"Evaluation of antiprotozoal and antimycobacterial activities of the resin glycosides and the other metabolites of Scrophularia cryptophila","volume":"15","author":"Tasdemir","year":"2008","journal-title":"Phytomedicine"},{"key":"10.1016\/j.ijid.2011.03.021_bib0435","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.phytochem.2006.11.002","article-title":"Sesquiterpene coumarins from Ferula szowitsiana and in vitro antileishmanial activity of 7-prenyloxycoumarins against promastigotes","volume":"68","author":"Iranshahi","year":"2007","journal-title":"Phytochemistry"},{"key":"10.1016\/j.ijid.2011.03.021_bib0440","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.biopha.2008.08.024","article-title":"Structure\u2013activity relationship of (\u2212) mammea A\/BB derivatives against Leishmania amazonensis","volume":"62","author":"Brenzan","year":"2008","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.ijid.2011.03.021_bib0445","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/j.bmc.2008.11.031","article-title":"Redox-active dinitrodiphenylthioethers against Leishmania: synthesis, structure\u2013activity relationships and mechanism of action studies","volume":"17","author":"Delf\u00edn","year":"2009","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.ijid.2011.03.021_bib0450","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.jsps.2009.08.005","article-title":"Inhibition of growth of Leishmania donovani promastigotes by newly synthesized 1,3,4-thiadiazole analogs","volume":"16","author":"Al-Qahtani","year":"2009","journal-title":"Saudi Pharm J"},{"key":"10.1016\/j.ijid.2011.03.021_bib0455","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1016\/j.ejmech.2009.01.016","article-title":"Synthesis and antileishmanial activity of novel 2,4,6-trisubstituted pyrimidines and 1,3,5-triazines","volume":"44","author":"Sunduru","year":"2009","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.ijid.2011.03.021_bib0460","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1016\/j.ejmech.2008.03.016","article-title":"Improved synthesis of seven aromatic Baylis\u2013Hillman adducts (BHA): evaluation against Artemia salina Leach. and Leishmania chagasi","volume":"44","author":"Barbosa","year":"2009","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.ijid.2011.03.021_bib0465","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.bmcl.2008.11.098","article-title":"Synthesis and evaluation of 2-pyridyl pyrimidines with in vitro antiplasmodial and antileishmanial activity","volume":"19","author":"Musonda","year":"2009","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.ijid.2011.03.021_bib0470","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1016\/j.ejmech.2008.03.039","article-title":"Nitroimidazolyl-1,3,4-thiadiazole-based anti-leishmanial agents: synthesis and in vitro biological evaluation","volume":"44","author":"Poorrajab","year":"2009","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.ijid.2011.03.021_bib0475","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.bmcl.2008.11.094","article-title":"Aryloxy cyclohexyl imidazoles: a novel class of antileishmanial agents","volume":"15","author":"Srinivas","year":"2009","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.ijid.2011.03.021_bib0480","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.biopha.2010.02.006","article-title":"Antitrypanosomal and antileishmanial activities of novel N-alkyl-(1-phenylsubstituted-beta-carboline)-3-carboxamides","volume":"64","author":"Tonin","year":"2010","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.ijid.2011.03.021_bib0485","doi-asserted-by":"crossref","first-page":"2880","DOI":"10.1016\/j.bmc.2010.03.018","article-title":"Trypanoside, anti-tuberculosis, leishmanicidal, and cytotoxic activities of tetrahydrobenzothienopyrimidines","volume":"18","author":"Aponte","year":"2010","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.ijid.2011.03.021_bib0490","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1016\/j.ejmech.2009.12.061","article-title":"Synthesis and in vitro activity of limonene derivatives against Leishmania and Trypanosoma","volume":"45","author":"Graebin","year":"2010","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.ijid.2011.03.021_bib0495","doi-asserted-by":"crossref","first-page":"6398","DOI":"10.1016\/j.bmc.2010.07.008","article-title":"Design, synthesis, and in vitro antiprotozoal, antimycobacterial activities of N-{2-[(7-chloroquinolin-4-yl)amino]ethyl}ureas","volume":"18","author":"Nava-Zuazo","year":"2010","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.ijid.2011.03.021_bib0500","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/S1748-0132(07)70084-1","article-title":"Magnetic nanoparticles for drug delivery","volume":"2","author":"Arruebo","year":"2007","journal-title":"Nanotoday"},{"key":"10.1016\/j.ijid.2011.03.021_bib0505","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.colsurfb.2009.09.001","article-title":"Biodegradable polymeric nanoparticles based drug delivery systems","volume":"75","author":"Kumari","year":"2010","journal-title":"Colloids Surf B Biointerfaces"},{"key":"10.1016\/j.ijid.2011.03.021_bib0510","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.addr.2007.05.003","article-title":"Nanosizing\u2014oral formulation development and biopharmaceutical evaluation","volume":"59","author":"Kesisoglou","year":"2007","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.ijid.2011.03.021_bib0515","doi-asserted-by":"crossref","first-page":"7260","DOI":"10.1016\/j.biomaterials.2005.05.044","article-title":"Therapeutic potential of nanoparticulate systems for macrophage targeting","volume":"26","author":"Chellat","year":"2005","journal-title":"Biomaterials"},{"key":"10.1016\/j.ijid.2011.03.021_bib0520","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.addr.2007.04.009","article-title":"Parasitic diseases: liposomes and polymeric nanoparticles versus lipid nanoparticles","volume":"59","author":"Date","year":"2007","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.ijid.2011.03.021_bib0525","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(00)00118-6","article-title":"Nanosuspensions as particulate drug formulations in therapy. Rationale for development and what we can expect for the future","volume":"47","author":"M\u00fcller","year":"2001","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.ijid.2011.03.021_bib0530","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0378-5173(02)00686-5","article-title":"Formulation of amphotericin B as nanosuspension for oral administration","volume":"254","author":"Kayser","year":"2003","journal-title":"Int J Pharm"},{"key":"10.1016\/j.ijid.2011.03.021_bib0535","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.1128\/AAC.44.9.2356-2360.2000","article-title":"Efficacy of oral cochleate-amphotericin B in a mouse model of systemic candidiasis","volume":"44","author":"Santangelo","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijid.2011.03.021_bib0540","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.ejpb.2007.06.015","article-title":"Lipid nanoparticles for alkyl lysophospholipid edelfosine encapsulation: development and in vitro characterization","volume":"68","author":"Mendoza","year":"2008","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.ijid.2011.03.021_bib0545","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1016\/j.peptides.2007.03.004","article-title":"Role of plant lipid transfer proteins in plant cell physiology\u2014a concise review","volume":"28","author":"Carvalho","year":"2007","journal-title":"Peptides"},{"key":"10.1016\/j.ijid.2011.03.021_bib0550","doi-asserted-by":"crossref","first-page":"5023","DOI":"10.1021\/jf000075m","article-title":"Purification and structural characterization of LTP1 polypeptides from beer","volume":"48","author":"J\u00e9gou","year":"2000","journal-title":"J Agric Food Chem"},{"key":"10.1016\/j.ijid.2011.03.021_bib0555","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1110\/ps.04799704","article-title":"Lipid binding in rice nonspecific lipid transfer protein-1 complexes from Oryza sativa","volume":"13","author":"Cheng","year":"2004","journal-title":"Protein Sci"},{"key":"10.1016\/j.ijid.2011.03.021_bib0560","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1093\/jxb\/erl288","article-title":"Isolation and characterization of a tomato non-specific lipid transfer protein involved in polygalacturonase-mediated pectin degradation","volume":"58","author":"Tomassen","year":"2007","journal-title":"J Exp Bot"},{"key":"10.1016\/j.ijid.2011.03.021_bib0565","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.peptides.2005.08.019","article-title":"Purification and characterization of non-specific lipid transfer proteins from the leaves of Pandanus amaryllifolius (Pandanaceae)","volume":"27","author":"Ooi","year":"2006","journal-title":"Peptides"},{"key":"10.1016\/j.ijid.2011.03.021_bib0570","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.phytochem.2009.04.021","article-title":"Isolation, purification and characterization of a nonspecific lipid transfer protein from Cuminum cyminum","volume":"70","author":"Zaman","year":"2009","journal-title":"Phytochemistry"},{"key":"10.1016\/j.ijid.2011.03.021_bib0575","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S0006-2952(01)00708-0","article-title":"Potential application of plant lipid transfer proteins for drug delivery","volume":"62","author":"Pato","year":"2001","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.ijid.2011.03.021_bib0580","doi-asserted-by":"crossref","first-page":"e432","DOI":"10.1371\/journal.pntd.0000432","article-title":"WR279,396, a third generation aminoglycoside ointment for the treatment of Leishmania major cutaneous leishmaniasis: a phase 2, randomized, double blind, placebo controlled study","volume":"3","author":"Ben Salah","year":"2009","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.ijid.2011.03.021_bib0585","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0304-3959(02)00041-6","article-title":"The interaction index: a measure of drug synergism","volume":"98","author":"Tallarida","year":"2002","journal-title":"Pain"},{"key":"10.1016\/j.ijid.2011.03.021_bib0590","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1590\/S0036-46652007000400012","article-title":"Combined effect of the essential oil from Chenopodium ambrosioides and antileishmanial drugs on promastigotes of Leishmania amazonensis","volume":"49","author":"Monzote","year":"2007","journal-title":"Rev Inst Med Trop Sao Paulo"},{"key":"10.1016\/j.ijid.2011.03.021_bib0595","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.phymed.2008.12.018","article-title":"Synergy research: approaching a new generation of phytopharmaceuticals","volume":"16","author":"Wagner","year":"2009","journal-title":"Phytomedicine"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971211000865?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971211000865?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,19]],"date-time":"2020-06-19T13:23:17Z","timestamp":1592572997000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971211000865"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8]]},"references-count":119,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2011,8]]}},"alternative-id":["S1201971211000865"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2011.03.021","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2011,8]]}}}